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Introduction
Axillary dissection represents an integral part of the
treatment of breast cancer for prognostic and curative
purposes. There is still a significant incidence (15–81%)
(1-5) of complications associated with axillary lympha-
denectomy, including lymphorrhea, lymphoceles, and
in rare cases lymphedema (swelling of the arm). It is pos-
sible to avoid axillary dissection in selected patients (T1
N0) using the sentinel lymph node technique. Howe-
ver, in all cases where T > 3 cm, and in patients with T1
N1 or with metastatic sentinel lymph node, conventional
axillary lymphadenectomy remains an integral part of
the primary surgical protocol for quadrantectomy and
mastectomy. 
Many different methodologies have been used to re-
duce seroma formation following axillary lymphade-
nectomy for breast cancer. These include suction drai-
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nage (6,7), topical application of tetracycline (8), clo-
sing and stitching the axillary fossa (9, 10), axillary dis-
section with axilloscopy (11), external compression (12,
13), and application of fibrin glue (14-16). To date, no
practical guidelines exist about suction drainage, and the
views of surgeons are different. Some surgeons believe
that it is best to remove the drain on the first day of the
post-operative period, some think the drain should be
left in place until the drained volume falls below 50
ml/day (17), while others feel that drainage could in fact
prolong and intensify the inflammatory stage of the
wound-healing process, with a subsequent increase in
seroma formation (18). 
Regardless of contradicting opinions, the possibility
of reducing the time of drainage during the postopera-
tive period, eliminating the need to discharge patients
with drainage in situ, may represent a valid solution for
reducing seroma formation. This prospective study eva-
luates the effectiveness of using fibrin glue  to reduce se-
roma formation following axillary lymphadenectomy for
breast cancer.
Patients and methods
Between January 2006 and March 2008, 90 patients were en-
rolled in the study. All patents had N+ breast adenocarcinoma and
required either quadrantectomy or modified radical mastectomy with
level I or II axillary lymphadenectomy, extending from the lower bor-
der of the axillary vein superiorly and from the medial border of the
smaller pectoral muscle medially, as far as the fourth intercostobra-
chial nerve inferiorly and to the edge of the latissimus dorsi lateral-
ly. For the axillary lymphadenectomy, the vascular-lymphatic bran-
ches were ligatured to limit the use of an electric scalpel. 
To be enrolled in the study, patients were required to have: no
alterations in their blood clotting or immune systems, or at least not
be receiving anticoagulant treatment; have no history of sensitisa-
tion to bovine aprotinin; no psychological changes; no uncompen-
sated diabetes or advanced liver disease; no severe obesity; and no
previous surgery on the axillary lymphatic system or any immedia-
te reconstructive surgery.  Short-term antibiotic prophylaxis was ap-
plied.
The enrolled patients were divided into two  randomized grou-
ps, each comprising 45 patients (30 quadrantectomies and 15 ma-
stectomies). After surgery, all patients were fitted with a suction drain
at the axillary fossa, which was activated 10 minutes after stitching
the skin. One group (control group) received the suction drain
without additional treatment, while the other group received fibrin
glue.
For patients in the treatment group, following fitting of the
drain, fibrin glue prepared with 500 IU/ml of thrombin was ap-
plied as a spray (2 ml, from a distance of 10 cm with 2 bars of pres-
sure) at the site of the quadrantectomy or mastectomy. Fibrin glue
prepared with 5 IU/ml of thrombin was also applied as a spray (2
ml) to the axillary fossa by approximately three minutes’ manual
compression. A compression dressing was applied over the treatment
site and kept in place for at least 24–72 hours. Fibrin glue for the
axillary fossa was prepared by diluting it to 5 IU/ml with calcium
chloride solution (20 mM), a concentration capable of maintaining
activation of the wound-healing process through a thick mesh of
fibrin fibrils.
Patients were discharged when the volume drained fell below 100
ml/day and suction drainage could be removed. One week later, pa-
tients underwent clinical and instrumental (ultrasound) assessment
for the presence of seroma, and any residue was suctioned out using
an echo-guided evacuative puncture, as necessary.  The primary out-
come measures of the study were a) the incidence of seroma, inclu-
ding total volume of serum drained, and b) number of evacuative
punctures required. A secondary outcome measure of the study was
the duration of the treatment up to the time of healing. Complica-
tions associated with the axillary lymphadenectomy procedure we-
re also recorded.  
The Wilcoxon rank-sum test was used to assess differences
between the two patient groups.
Results
Factors as age, size of tumor and its ratio to the re-
sidual breast volume following surgery, the number of
lymph node removed and the number of metastatic
lymph nodes did not represent significant variables in
terms of seroma magnitude.
All patients were discharged 3-4 days following sur-
gery. Two patient in the control group was discharged
with the drain in situ because the serum volume was grea-
ter than 100 ml/day. The patients was controlled by fa-
mily doctor at home and the drain was removed in days
7 and 8 p.o.
Compared with patients in the control group, patients
in the fibrin glue group had a significantly lower drai-
nage volume (120 [60–350] versus 250 [110–550] ml;
p = 0.004), fewer evacuative punctures (2 [0–3] versus
4 [1–5]), and a significantly reduced mean seroma du-
ration, i.e. healing time (11.2 [4–21] versus 17.5 (4-32)
days; p = 0.02). The incidence of complications was 20%
(8 cellulitis and 1 wound diastasis) and 28,8% (11 cel-
lulitis and 2 wound diastasis) in patients who underwent
surgery with and without fibrin glue, respectively. No
significant relationship was observed in either patient
group between the magnitude of seroma formation and
the type of surgical procedure (quadrantectomy or ma-
stectomy).  
Discussion
Breast cancer surgery, in particular axillary lympha-
denectomy, has changed in the last few years with the
advent of the sentinel lymph node technique (11). Howe-
ver, even today there are a number of situations where
a conventional axillary lymphadenectomy is indicated,
including patients with tumours greater than 3 cm in
diameter, with positive or suspect axillary lymph nodes
at objective examination or instrumental imaging, or
with a positive sentinel lymph node. In this group of pa-
tients, the axillary lymphadenectomy still has compli-
cations, in particular seroma formation (15-81%) (1-5),
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which can delay the patient’s discharge, healing and adju-
vant radiotherapy and chemotherapy treatments. 
The formation of seroma can result from a lesion of
the axillary lymphatic vessels (2) or from an inflamma-
tory reaction (18), which may also be prolonged and in-
tensified by the suction drainage (19). The removal of
drainage for some surgeons is indicated when the volu-
me per day is less than 50 ml2, but we prefer to remo-
ve the drainage when the volume per day is less than 100
ml, as in our experience drains do not prevent seroma
formation, and they also dictate the date of discharge,
resulting in a longer stay (3). A number of surgeons be-
lieve that it is possible to discharge patients with the drai-
nage in situ (3), despite the associated discomfort and
increase in percentage infection rate. This issue of drai-
nage management at home arises in cases of procedures
carried out in day surgery. 
Many published articles on the usefulness of drai-
nage following axillary lymphadenectomy contradict ea-
ch another with regard to seroma control, magnitude
and duration. Somers et al.(5) compared patients with
or without drainage and found that there was greater
incidence and degree of seroma, with longer duration,
in patients without suction drainage. Porter et al. (20)
reported non-significant difference in the incidence and
degree of seroma between patients with suction drai-
nage (73%) versus patients without suction drainage
(89%). Divino et al. (6) reported 6% incidence of se-
roma for patients with drainage, compared with 40%
for patients without. Petrek et al. (21) demonstrated a
relationship between the magnitude of the seroma and
lymph node positivity based on metastasis or earlier
lymph node biopsies. Burak et al. (22) noted a rela-
tionship between seroma magnitude and patient age.
Salmon et al. (23) reported a positive correlation
between the incidence of seroma and size of the brea-
st removed. Using ultrasound monitoring, Jeffrey et al.
(24) reported 92% seroma incidence in patients without
drainage, and sharing the view of others that repeated
suctions may be the cause of infections of the axillary
fossa (25-26) using evacuative puncture only in symp-
tomatic cases (42%). 
To reduce seroma magnitude, there have been nu-
merous reports of the benefits of using external com-
pression dressing (27), immobilization of the arm (28),
sutures to close the axillary fossa (29), excessive use of
the electric scalpel compared with ligature of the lympha-
tic branches (20-30), multiple drains (21), different ty-
pe of suction (high- or low-pressure) (31). The use of
fibrin glue has also produced contrasting results: re-
duction of seroma according to Moore et al. (14) and
Gilly et al. (32); and no difference in seroma formation
compared with patients treated without fibrin glue, ac-
cording to Burak et al. (22), Langer et al. (33) and Din-
smore et al. (34). The latter authors attributed the lack
of benefit to the presence of drainage possibly interfe-
ring with the stabilization of a fibrin clot, and with clo-
sure of the lymphatic capillaries.  Fibrin glue interacts
with the tissues damaged during the surgical procedu-
re, favoring the growth of fibroblasts and wound hea-
ling. It favors hemostasis by preventing hematomas, whi-
ch delay the surgical healing processes; makes the
lymphatic branches impermeable, reducing seroma for-
mation; and makes it possible to close the dead spaces
through tissue adhesion. 
A number of papers have presented comparative stu-
dies of patients with and without fibrin glue in the axil-
lary fossa. In a study of 24 patients who underwent qua-
drantectomy or mastectomy with axillary lymphade-
nectomy, Gioffre’ Florio et al. (35) demonstrated that
the use of fibrin glue reduced seroma magnitude. In a
group of 186 patients, Tasinato et al. (36) reported a re-
duction in seroma magnitude, duration and the num-
ber of evacuative suctions on patients on whom fibrin
glue spray was used, compared with patients whose axil-
lary fossa was only washed with povidone-iodine or sa-
line solution. In a group of 20 patients who underwent
quadrantectomy with axillary lymphadenectomy, Tirelli
et al. (37) noted a reduction in the magnitude and du-
ration of seromas in patients in whom fibrin glue was
used. In a study involving 116 patients who underwent
a surgical procedure of quadrantectomy or mastectomy
with axillary lymphadenectomy, Jain et al. (38) repor-
ted a seroma incidence of around 40%, with a reduc-
tion in seroma magnitude in mastectomy patients in
whom fibrin glue was used, although a significant dif-
ference was not observed between quadrantectomy pa-
tients treated with or without fibrin glue. The study de-
monstrated that suction drainage did not limit the in-
cidence or magnitude of seromas, and that it was asso-
ciated with extended time spent in hospital and post-
operative pain. Yet in a study of 87 patients, Soon et al.
(39) showed that, among patients who underwent qua-
drantectomy or mastectomy with axillary lymphade-
nectomy, there was no difference in terms of the inci-
dence of seromas with or without the use of suction drai-
nage, and that, for the group of patients without drai-
nage, the seromas formed in greater magnitude and for
a longer duration, but with a lower percentage of com-
plications. Kuroi (40), in a meta-analysis of 51 rando-
mized controlled trials, 7 prospective studies and 7 re-
trospective studies, showed that there was moderate evi-
dence to support a risk for seroma formation in subjects
with higher body weight, extended radical mastectomy
and greater drainage volume in the first 3 days; with re-
gard to the use of adhesive glue, many retrospective stu-
dies failed to show any significant effect on seroma for-
mation.
Based on our experience, and reviewing data from
the literature, it seems that the magnitude and duration
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of the seromas are limited, but they are present in over
80% of patients, without significant differences between
mastectomy and quadrantectomy. In our opinion the use
of fibrin glue  may therefore be useful in traditional brea-
st cancer surgery for reducing magnitude and duration
of the seroma, and shortening the stay in hospital whi-
ch, in this pathology too, is increasingly performed in
day surgery.
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